Stock listing
4DN Stock Price, News, Filings & Events — Denali Therapeutics Inc.
Selected listing: 4DN · TRADEGATE · EUR · DE
This page tracks Denali Therapeutics Inc.'s 4DN:TRADEGATE listing on TRADEGATE in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 4DN:TRADEGATE. 4DN:TRADEGATE is the stock-level entry point for investors researching Denali Therapeutics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- 4DN:TRADEGATE
- Asset type
- Stock
- Market cap
- $3.37B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- TRADEGATE
- Currency
- EUR
Denali Therapeutics Inc. 4DN:TRADEGATE stock context
This page tracks Denali Therapeutics Inc.'s 4DN:TRADEGATE listing on TRADEGATE in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 4DN:TRADEGATE. 4DN:TRADEGATE is the stock-level entry point for investors researching Denali Therapeutics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Denali Therapeutics Inc.
Denali Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights
August 6, 2026
Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026
July 27, 2026
Denali Therapeutics to Give Opening Plenary Address at Alzheimer’s Association International Conference (AAIC) 2026 and Highlight Breakth...
July 9, 2026
Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 Million
June 18, 2026
Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease
May 21, 2026
Research Denali Therapeutics Inc.
Denali Therapeutics Inc. investor report
Review AI stock analysis and investor report context for 4DN:TRADEGATE.
Denali Therapeutics Inc. company profile
View the public company page for Denali Therapeutics Inc. on 6ix.
Denali Therapeutics Inc. news
Read company news and market updates connected to Denali Therapeutics Inc..
Denali Therapeutics Inc. investor events
Find investor webinars, events, and replay context for Denali Therapeutics Inc..
Alternate listings
DNLI:NASDAQ
US · USD
Alternate listing for Denali Therapeutics Inc.; the primary context on this page is 4DN:TRADEGATE.
A2H9G8:LSX
DE · EUR
Alternate listing for Denali Therapeutics Inc.; the primary context on this page is 4DN:TRADEGATE.
4DN:GETTEX
DE · EUR
Alternate listing for Denali Therapeutics Inc.; the primary context on this page is 4DN:TRADEGATE.
DNLI:BX
CH · CHF
Alternate listing for Denali Therapeutics Inc.; the primary context on this page is 4DN:TRADEGATE.
A2H9G8:LS
DE · EUR
Alternate listing for Denali Therapeutics Inc.; the primary context on this page is 4DN:TRADEGATE.
D2NL34:BMFBOVESPA
BR · BRL
Alternate listing for Denali Therapeutics Inc.; the primary context on this page is 4DN:TRADEGATE.
4DN:FWB
DE · EUR
Alternate listing for Denali Therapeutics Inc.; the primary context on this page is 4DN:TRADEGATE.
DNLI:BOATS
US · USD
Alternate listing for Denali Therapeutics Inc.; the primary context on this page is 4DN:TRADEGATE.
4DN:DUS
DE · EUR
Alternate listing for Denali Therapeutics Inc.; the primary context on this page is 4DN:TRADEGATE.
4DN:MUN
DE · EUR
Alternate listing for Denali Therapeutics Inc.; the primary context on this page is 4DN:TRADEGATE.
4DN:SWB
DE · EUR
Alternate listing for Denali Therapeutics Inc.; the primary context on this page is 4DN:TRADEGATE.